当前位置:首页 - 行情中心 - 美好医疗(301363) - 财务分析

美好医疗

(301363)

  

流通市值:128.68亿  总市值:196.15亿
流通股本:3.73亿   总股本:5.69亿

美好医疗(301363)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.57亿元,每股收益0.10元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益378453.37万元,未分配利润163077.79万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产425215.36万元,负债46762.00万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入403,077,520.811,625,486,540.421,194,474,058.15732,816,682.76
营业总成本337,442,473.351,273,131,275.66948,450,698.88599,878,465.56
其他经营收益
营业利润65,280,178.23325,197,321.53237,755,302.27128,075,365.37
利润总额65,301,710.11324,696,407.61237,798,946.55128,111,405.32
净利润56,683,601.11283,080,971.9208,202,331.16114,302,142.45
每股收益
其他综合收益-11,024,063.842,384,985.121,867,006.7325,921,615.41
综合收益总额45,659,537.31325,465,957230,069,337.89140,223,757.86
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,461,298,469.762,455,066,464.222,441,744,660.552,384,658,958.76
非流动资产:
非流动资产合计1,790,855,172.461,778,806,955.081,737,752,688.631,621,228,503.06
资产总计4,252,153,642.224,233,873,419.34,179,497,349.184,005,887,461.82
流动负债:
流动负债合计392,712,646.31429,591,776.45403,851,160.92341,314,135.85
非流动负债:
非流动负债合计74,907,304.9570,842,222.3973,676,412.6769,628,673.23
负债合计467,619,951.26500,433,998.84477,527,573.59410,942,809.08
所有者权益(或股东权益):
归属于母公司股东权益合计3,784,533,690.963,733,439,420.463,701,969,775.593,594,944,652.74
股东权益合计3,784,533,690.963,733,439,420.463,701,969,775.593,594,944,652.74
负债和股东权益合计4,252,153,642.224,233,873,419.34,179,497,349.184,005,887,461.82
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计441,594,099.821,777,851,140.161,295,860,795.12853,126,066.86
经营活动现金流出小计370,798,638.121,425,699,954.651,073,887,376.47741,370,351.28
经营活动产生的现金流量净额70,795,461.7352,151,185.51221,973,418.65111,755,715.58
投资活动产生的现金流量:
投资活动现金流入小计514,798,795.133,156,754,218.482,138,823,892.51,703,802,474.05
投资活动现金流出小计349,241,577.163,242,276,314.242,379,055,9421,544,270,814.71
投资活动产生的现金流量净额165,557,217.97-85,522,095.76-240,232,049.5159,531,659.34
筹资活动产生的现金流量:
筹资活动现金流入小计29,837,100162,163,069.9286,179,310.656,181,139.86
筹资活动现金流出小计33,084,959.08143,749,231.0876,026,115.6663,943,633.99
筹资活动产生的现金流量净额-3,247,859.0818,413,838.8410,153,194.94-7,762,494.13
汇率变动对现金及现金等价物的影响-20,298,435.68-18,125,590.891,343,262.033,453,244.45
现金及现金等价物净增加额212,806,384.91266,917,337.7-6,762,173.88266,978,125.24
期末现金及现金等价物余额1,297,834,290.961,085,027,906.05811,348,394.471,085,088,693.59
补充资料:
现金及现金等价物的净增加额-266,917,337.7-266,978,125.24
最新报告期:2026-05-06
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中信证券宋硕,陈竹,曾令鹏0.650.871.002026-05-06
国信证券凌珑,彭思宇,陈曦炳0.700.830.982026-05-04
长江证券彭英骐,徐晓欣0.640.861.092026-04-27
东方证券伍云飞0.700.841.012026-04-23
华源证券刘闯,林海霖0.690.891.142026-04-22
TOP↑